Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Cash Flow Quality Index
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Cash Flow Quality Index of 0.49x as of September 2025. Operating cash flow of CN¥110.78 Million is below net income of CN¥224.56 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Tianjin Zhongxin Pharmaceutical Group Co (600329) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow Quality Index (2001–2024)
Historical Cash Flow Quality Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600329 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year earnings quality comparison for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For live market cap and the full company financial profile, see 600329 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.42x | CN¥924.67 Million | CN¥2.22 Billion | ▼ -41.3% |
| 2023 | 0.71x | CN¥688.49 Million | CN¥968.71 Million | ▼ -8.4% |
| 2022 | 0.78x | CN¥677.25 Million | CN¥873.26 Million | ▼ -28.4% |
| 2021 | 1.08x | CN¥852.40 Million | CN¥786.88 Million | ▲ +9.7% |
| 2020 | 0.99x | CN¥671.42 Million | CN¥679.66 Million | ▲ +26.7% |
| 2019 | 0.78x | CN¥495.49 Million | CN¥635.36 Million | ▲ +26.5% |
| 2018 | 0.62x | CN¥350.14 Million | CN¥567.79 Million | ▲ +7446.5% |
| 2017 | -0.01x | CN¥-3.97 Million | CN¥473.26 Million | ▼ -100.8% |
| 2016 | 1.03x | CN¥419.90 Million | CN¥407.61 Million | ▲ +30.8% |
| 2015 | 0.79x | CN¥360.58 Million | CN¥457.87 Million | ▲ +4.2% |
| 2014 | 0.76x | CN¥286.85 Million | CN¥379.44 Million | ▲ +27.7% |
| 2013 | 0.59x | CN¥213.44 Million | CN¥360.59 Million | ▲ +1203.6% |
| 2012 | 0.05x | CN¥20.81 Million | CN¥458.29 Million | ▼ -93.0% |
| 2011 | 0.65x | CN¥173.88 Million | CN¥266.59 Million | ▲ +50.5% |
| 2010 | 0.43x | CN¥139.04 Million | CN¥320.84 Million | ▲ +42.8% |
| 2009 | 0.30x | CN¥83.41 Million | CN¥274.91 Million | ▼ -61.4% |
| 2008 | 0.79x | CN¥155.77 Million | CN¥198.22 Million | ▼ -72.0% |
| 2005 | 2.81x | CN¥261.91 Million | CN¥93.21 Million | ▲ +2146.3% |
| 2004 | 0.13x | CN¥10.50 Million | CN¥83.91 Million | ▼ -82.8% |
| 2003 | 0.73x | CN¥76.57 Million | CN¥105.15 Million | ▼ -63.5% |
| 2002 | 2.00x | CN¥187.60 Million | CN¥93.98 Million | ▼ -6.8% |
| 2001 | 2.14x | CN¥157.73 Million | CN¥73.65 Million | — |